Experimental and Molecular Therapeutics

Abstract 2812: Status of TGFbeta signaling determines PARP inhibitor sensitivity in head and neck cancer.

Experimental and Molecular Therapeutics

Qi Liu, Lin Ma, Luis Palomero, Miquel Àngel Pujana, Trevor Jones, Patrick Ha, John Murnane, Mary Helen Barcellos-Hoff